Cargando…

Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients

Patients with heart transplantation (HT) have an increased risk of COVID-19 disease and the efficacy of vaccines on antibody induction is lower, even after three or four doses. The aim of our study was to assess the efficacy of four doses on infections and their interplay with immunosuppression. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masetti, Marco, Scuppa, Maria Francesca, Aloisio, Alessio, Giovannini, Laura, Borgese, Laura, Manno, Stefania, Tazza, Beatrice, Pascale, Renato, Bonazzetti, Cecilia, Caroccia, Natascia, Sabatino, Mario, Spitaleri, Giosafat, Viale, Pierluigi, Giannella, Maddalena, Potena, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053932/ https://www.ncbi.nlm.nih.gov/pubmed/36985328 http://dx.doi.org/10.3390/microorganisms11030755

Ejemplares similares

1089. Evaluation of breakthrough infections in solid organ transplant recipients: the prospective CONTRAST cohort
por: Tazza, Beatrice, et al.
Publicado: (2022)

Role of Immunosuppression on Efficacy of Anti-SARS-CoV-2 Vaccines in Heart Transplanted (HT) Patients
por: Masetti, M., et al.
Publicado: (2022)

Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

214. The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis.
por: Rinaldi, Matteo, et al.
Publicado: (2022)

The impact of preservation fluid culture on graft site arteritis: A systematic review and meta‐analysis
por: Rinaldi, Matteo, et al.
Publicado: (2022)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Association of Patients’ Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis
por: Reyna-Villasmil, Eduardo, et al.
Publicado: (2022)

The controversial bond between COVID-19 and bacterial superinfections
por: Bonazzetti, Cecilia, et al.
Publicado: (2023)

Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study
por: Rinaldi, Matteo, et al.
Publicado: (2023)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Novel therapeutic and diagnostic management of heart transplant patients
por: D'Addio, Francesca, et al.
Publicado: (2015)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic
por: Rinaldi, Eugenia, et al.
Publicado: (2022)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

Telemedicine (TM) during SARS-CoV-2 Outbreak
por: Masetti, M., et al.
Publicado: (2021)

Proper Left Ventricular Assist Device Outpatients Monitoring: VAD Coordinator Interface Despite COVID-19 Pandemic
por: Boschi, S., et al.
Publicado: (2021)

How much European prescribing physicians know about invasive fungal infections management?
por: Valerio, Maricela, et al.
Publicado: (2015)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
por: Gatti, Milo, et al.
Publicado: (2022)

Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study
por: Bonazzetti, Cecilia, et al.
Publicado: (2022)

Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies
por: Potena, Luciano, et al.
Publicado: (2013)

Pirfenidone as a novel cardiac protective treatment
por: Aimo, Alberto, et al.
Publicado: (2021)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
por: Cojutti, Pier Giorgio, et al.
Publicado: (2022)

Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis
por: Gatti, Milo, et al.
Publicado: (2022)

Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort
por: Giannella, Maddalena, et al.
Publicado: (2022)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

The Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose
por: Cohen, Idan, et al.
Publicado: (2023)

Gender-Related Differences in Heart Failure Biomarkers
por: Cediel, Germán, et al.
Publicado: (2021)

COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
por: Novi, Giovanni, et al.
Publicado: (2020)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

2257. BDG-Guided Management of Empirical Antifungal Therapy: a Real-life Experience in a Hospital-Wide Context with High Incidence of Non-albicans Candida Infection
por: Marconi, Lorenzo, et al.
Publicado: (2019)

Effective Containment of a COVID-19 Subregional Outbreak in Italy Through Strict Quarantine and Rearrangement of Local Health Care Services
por: Tedeschi, Sara, et al.
Publicado: (2021)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
por: Gatti, Milo, et al.
Publicado: (2021)

Breakthrough Pain: The Importance of Baseline Analgesic Regimen with Opioids
por: Zampi, Maddalena, et al.
Publicado: (2012)

Exposure to psychotropic medications and COVID-19 course after hospital admission: Results from a prospective cohort study
por: D'Andrea, G., et al.
Publicado: (2023)

Breakthroughs in microbiology made possible with organoids
por: Ramírez-Flores, Carlos J., et al.
Publicado: (2021)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8hjssigr4p30os2ib84vng948t